Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mangosteen juice is a beverage made from the fruit of *Garcinia mangostana*, commonly known as mangosteen. It is rich in nutrients such as vitamin C, fiber, and unique plant compounds called xanthones, which are believed to have strong antioxidant properties. Mangosteen juice has been studied for its potential health benefits including antioxidant effects (neutralizing free radicals), anti-inflammatory activity (reducing markers like C-reactive protein), immune system support, blood sugar regulation, and possible anticancer effects. Some small clinical studies suggest that regular consumption may increase antioxidant capacity in the bloodstream and reduce inflammation without significant side effects on liver or kidney function[1][3][6]. However, most evidence comes from animal studies or small human trials; large-scale clinical data are lacking. Mangosteen juice is marketed primarily as a dietary supplement or functional food rather than a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on mangosteen juice.